WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020

Jul 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-07-28

Reporting Person: MONTECALVO DAVID A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-28	Common Stock	M	10792.00	$71.79	Acquired	15732.42	Direct
2020-07-28	Common Stock	M	3000.00	$83.47	Acquired	18732.42	Direct
2020-07-28	Common Stock	S	716.00	$266.058	Disposed	18016.42	Direct
2020-07-28	Common Stock	S	7773.00	$264.1315	Disposed	10243.42	Direct
2020-07-28	Common Stock	S	2881.00	$265.1292	Disposed	7362.42	Direct
2020-07-28	Common Stock	S	138.00	$265.8507	Disposed	7224.42	Direct
2020-07-28	Common Stock	S	3000.00	$265.9769	Disposed	4224.42	Direct
2020-07-29	Common Stock	M	5358.00	$83.47	Acquired	9582.42	Direct
2020-07-29	Common Stock	S	3273.00	$270.7038	Disposed	6309.42	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-28	Stock Option (Right to Buy)	$71.79	M	10792.00	Disposed	2026-09-26	Common Stock (10792.00)	Direct
2020-07-28	Stock Options (Right to buy)	$83.47	M	3000.00	Disposed	2027-02-21	Common Stock (3000.00)	Direct
2020-07-29	Stock Options (Right to buy)	$83.47	M	5358.00	Disposed	2027-02-21	Common Stock (5358.00)	Direct

Footnotes

F1: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $263.80 to $264.79, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.

F2: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $264.80 to $265.77, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.

F3: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.80 to $265.87, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.

F4: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.9762 to $265.9769, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.